IDEAYA Biosciences, Inc.IDYANASDAQ
Loading
Operating cash flow minus capital expenditures
Percentile
P38
Within normal range
vs 5Y Ago
-1.3x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-73.47M | +70.8% |
| 2024 | $-251.44M | -113.8% |
| 2023 | $-117.59M | -29.8% |
| 2022 | $-90.62M | -55.1% |
| 2021 | $-58.42M | -206.3% |
| 2020 | $54.97M | +235.2% |
| 2019 | $-40.67M | -38.7% |
| 2018 | $-29.33M | -109.8% |
| 2017 | $-13.98M | - |